  See all
 |
Articles: Colorectal Cancer/Polyps |
Prior Articles
Alpha-Keto acid metabolites of organoselenium compounds inhibit histone deacetylase activity in human colon cancer cells
Carcinogenesis, 07/31/09
Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Recombinant Human Intestinal Trefoil Factor Oral Spray for Prevention of Oral Mucositis in Patients With Colorectal Cancer Who Are Receiving Fluorouracil-Based Chemotherapy
Journal of Clinical Oncology, 07/30/09 Fish consumption and the risk of colorectal cancer: the Ohsaki Cohort Study
British Journal of Cancer, 07/30/09 Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease
The Lancet Oncology, 07/30/09 Racial Differences in Advanced Colorectal Cancer Outcomes and Pharmacogenetics: A Subgroup Analysis of a Large Randomized Clinical Trial
Journal of Clinical Oncology, 07/30/09 Health-related quality of life, faecal continence and bowel function in rectal cancer patients after chemoradiotherapy followed by radical surgery
Supportive Care in Cancer, 07/30/09 Development and feasibility assessment of telephone-delivered supportive care to improve outcomes for patients with colorectal cancer: pilot study of the CONNECT intervention
Supportive Care in Cancer, 07/30/09 Inhibition of metastatic potential in colorectal carcinoma in vivo and in vitro using immunomodulatory drugs (IMiDs)
British Journal of Cancer, 07/30/09 MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer
British Journal of Cancer, 07/30/09 Using the results of a baseline and a surveillance colonoscopy to predict recurrent adenomas with high-risk characteristics
Annals of Internal Medicine, 07/29/09 Associations between lifestyle factors and quality of life among older long-term breast, prostate, and colorectal cancer survivors
Cancer, 07/28/09 Colorectal cancer risk perception on the basis of genetic test results in individuals at risk for Lynch syndrome
Journal of Clinical Oncology, 07/27/09 Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer
Cancer, 07/27/09 Identification of phosphorylated p38 as a novel DAPK-interacting partner during TNFα-induced apoptosis in colorectal tumor cells
American Journal of Pathology, 07/27/09 Phase IV study of bevacizumab in combination with infusional fluorouracil, leucovorin and irinotecan (FOLFIRI) in first-line metastatic colorectal cancer
Oncology (Karger), 07/24/09 Integration of panitumumab into the treatment of colorectal cancer
Critical Reviews in Oncology/Hematology, 07/24/09 Carbonic anhydrase 9 is a predictive marker of survival benefit from lower dose of bevacizumab in patients with previously treated metastatic colorectal cancer
BMC Cancer, 07/23/09
Free full text
Clinical implications of the colorectal cancer risk associated with MUTYH mutation
Journal of Clinical Oncology, 07/23/09 Risk of high-grade skin rash in cancer patients treated with cetuximab – an antibody against epidermal growth factor receptor: systemic review and meta-analysis
Oncology (Karger), 07/23/09 Clinical predictors of severe cetuximab-induced rash: observations from 933 patients enrolled in North Central Cancer Treatment Group Study N0147
Oncology (Karger), 07/23/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|
